Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer

Annals of Surgical Oncology

Volumn 5, Issue 2, 1998, Pages 150-158

  Danforth Jr , David N ^a,b   Zujewski, JoAnne ^a   O'Shaughnessy, Joyce ^a   Riseberg, David ^a   Steinberg, Seth M ^a   McAtee, Nanette ^a   Noone, Marianne ^a   Chow, Catherine ^b   Chaudhry, Usha ^a   Lippman, Marc ^a   Jacobson, Joan ^a   Okunieff, Paul ^a   Cowan, Kenneth H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast radiotherapy; Inflammatory breast cancer; Mastectomy; Neoadjuvant chemotherapy; Stage III breast cancer

Indexed keywords

CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; TAMOXIFEN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PROGNOSIS; TREATMENT PLANNING;

ADULT; AGED; AXILLA; BIOPSY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; CLAVICLE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NECK; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SURVIVAL RATE; THORACIC NEOPLASMS;

EID: 0344528645     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303848     Document Type: Article

References (27)

1. Haagensen CD. Diseases of the Breast. Philadelphia: WB Saunders, 1971:623-8.
2. Duggan D. Local therapy of locally advanced breast cancer. Oncology 1991;5:67-80.
3. Spanos W, Montague E, Fletcher G. Late complications of radiation only for advanced breast cancer. Int J Radiat Oncol Biol Phys 1980;6:1473-6.
4. Morrow M, Hoffman PC, Weichselbaum RR. Special therapeutic problems. In: Harris JR, Hellman S. Henderson IC, Kinne DW, eds. Diseases of the Breast. Philadelphia: JB Lippincott, 1991:767-774.
5. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: DeVita V, Hellman S, Rosenberg S, eds. Cancer: Principles & Practice of Oncology, 4th ed. Philadelphia: JB Lippincott, 1993:1264-1332.
6. Swain S, Sorace RA, Bagley CS, et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res 1987;47:3889-94.
7. Danforth DN, Lippman ME, McDonald H, et al. Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancer. Am Surg 1990;56:6-11.
8. Hortobagyi GN, Ames FC, Buzdar AU, et al. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 1988;62:2507-16.
9. Cocconi G, di Blasio B, Bisagni G, et al. Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. Am J Clin Oncol 1990;13:226-32.
10. Gardin G, Rosso R, Campora E, et al. Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogenously treated with a combined modality approach. Eur J Cancer 1995;31A:1428-33.
11. Del Castillo C, Baeza MR, Cornejo J, et al. Conservative surgery (CS) after pre-operative therapy (POT) in locally advanced breast cancer (LABC). Proc Annu Meet Am Soc Clin Oncol 1995;14: A241. Abstract.
12. Machiavelli M, Romero A, Cuevas M, et al. Multidisciplinary treatment for locally advanced breast carcinoma (LABC). Proc Annu Meet Am Soc Clin Oncol 1995;14:A188. Abstract.
13. Perloff M, Lesnick GJ. Korzun A, et al. Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a cancer and leukemia group B study. J Clin Oncol 1988; 6:261-9.
14. De Lena M, Varini M, Zucali R. et al. Multimodal treatment for locally advanced breast cancer. Cancer Clin Trials 1981;4:229-36.
15. Shanta V, Krishnamurthi S. Preoperative multimodal therapy for locally advanced non-inflammatory breast cancer: Clin Oncol 1991;3:137-40.
16. Singletary SE, McNeese MD, Hortobagyi GN. Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 1992;69:2849-52.
17. Belembaogo E, Feillel V, Chollet P, et al. Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer 1992;28A: 896-900.
18. Jacquillat C, Weil M, Baillet, et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 1990;66:119-29.
19. Beahrs OH, Myers MH, eds. Manual for Staging of Cancer: American Joint Committee on Cancer. 2nd ed. Philadelphia: JB Lippincott, 1983:127-33.
20. Sorace RA, Bagley CS, Lichter AS, et al. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. World J Surg 1985;9:775-85.
21. O'Shaughnessy JA, Denicoff AM, Venzon DJ. A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients. Ann Oncol 1994;5:709-16.
22. The Breast Cancer Task Force Treatment Committee NCI National Cancer Institute. Breast Cancer: Suggested Protocol Guidelines for Combination Chemotherapy Trials and for Combined Modality Trials. Washington, DC: United States Department of Health, Education, and Welfare Publication 78-1192, 1978.
23. Lichter AS, Fraass, BA, van de Geijn J, et al. A technique tor field matching in primary breast irradiation. Int J Radiat Oncol Biol Phys 1983;9:263-70.
24. Fraass, BA, Lichter AS, McShan DL, et al. The influence of lung density corrections on treatment planning for primary breast cancer. Int J Radiat Oncol Biol Phys 1988;14:179-90.
25. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Amer Stat Assoc 1958;53:457-81.
26. Lawrence WT, Talbot TL, Norton JA. Preoperative or postoperative doxorubicin hydrochloride (Adriamycin): Which is better for wound healing? Surgery 1986;100:9-12.
27. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-401.